Global Viral Inactivation Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

Global Viral Inactivation Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

The Global Viral Inactivation Market is expected to grow from USD 523.04 Million in 2018 to USD 1,289.58 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.75%.
The positioning of the Global Viral Inactivation Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Viral Inactivation Market including are Charles River Laboratories International, Inc., Clean Cells Inc., Merck KGAA, Sartorius AG, Viral Inactivated Plasma Systems SA, Danaher Corporation, Parker Hannifin Corporation, Rad Source Technologies, Inc., Texcell, Inc., and Wuxi Pharmatech Inc..
On the basis of Method, the Global Viral Inactivation Market is studied across Pasteurization and Solvent Detergent Method.
On the basis of Product, the Global Viral Inactivation Market is studied across Kits & Reagents, Services, and Viral Inactivation Systems & Accessories.
On the basis of Application, the Global Viral Inactivation Market is studied across Blood & Blood Product, Cellular & Gene Therapy Product, Stem Cell Product, Tissues & Tissue Product, and Vaccines & Therapeutic.
On the basis of End User, the Global Viral Inactivation Market is studied across Academic Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Viral Inactivation Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Viral Inactivation Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Viral Inactivation Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Viral Inactivation Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Viral Inactivation Market

The report answers questions such as:

1. What is the market size of Viral Inactivation market in the Global?
2. What are the factors that affect the growth in the Global Viral Inactivation Market over the forecast period?
3. What is the competitive position in the Global Viral Inactivation Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Viral Inactivation Market?
5. What are the opportunities in the Global Viral Inactivation Market?
6. What are the modes of entering the Global Viral Inactivation Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
3. Executive Summary
3.1. Viral Inactivation Market: Outlook
3.2. Viral Inactivation Market: Current State & Forecast
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.2.1. Market Sizing & Forecasting, by Method
4.2.2. Market Sizing & Forecasting, by Product
4.2.3. Market Sizing & Forecasting, by Application
4.2.4. Market Sizing & Forecasting, by End User
4.2.5. Market Sizing & Forecasting, by Geography
5. Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunities
5.4. Challenges
6. Industry Insight
6.1. Porter’s Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Client Customizations
7. Global Viral Inactivation Market, by Method
7.1. Pasteurization
7.2. Solvent Detergent Method
8. Global Viral Inactivation Market, by Product
8.1. Kits & Reagents
8.2. Services
8.3. Viral Inactivation Systems & Accessories
9. Global Viral Inactivation Market, by Application
9.1. Blood & Blood Product
9.2. Cellular & Gene Therapy Product
9.3. Stem Cell Product
9.4. Tissues & Tissue Product
9.5. Vaccines & Therapeutic
10. Global Viral Inactivation Market, by End User
10.1. Academic Research Institutes
10.2. Contract Research Organizations
10.3. Pharmaceutical & Biotechnology Companies
11. Global Viral Inactivation Market, by Geography
11.1. Americas
11.1.1. Argentina
11.1.2. Brazil
11.1.3. Canada
11.1.4. Mexico
11.1.5. United States
11.2. Asia-Pacific
11.2.1. Australia
11.2.2. China
11.2.3. India
11.2.4. Japan
11.3. Europe, Middle East & Africa
11.3.1. France
11.3.2. Germany
11.3.3. Italy
11.3.4. Spain
11.3.5. United Kingdom
12. Competitive Landscape
12.1. 360iResearch FPNV Positioning Matrix
12.1.1. 360iResearch Quadrants
12.1.1.1. Forefront
12.1.1.2. Pathfinders
12.1.1.3. Niche
12.1.1.4. Vital
12.1.2. Business Strategy
12.1.2.1. Business Growth
12.1.2.2. Industry Coverage
12.1.2.3. Financial Viability
12.1.2.4. Channel Support
12.1.3. Product Satisfaction
12.1.3.1. Value for Money
12.1.3.2. Ease of Use
12.1.3.3. Product Features
12.1.3.4. Customer Support
12.2. Market Vendor Ranking Analysis
12.3. Competitive News Feed Analysis
13. Company Usability Profiles
13.1. Charles River Laboratories International, Inc.
13.1.1. Overview
13.1.2. Strategy
13.1.3. SWOT
13.2. Clean Cells Inc.
13.2.1. Overview
13.2.2. Strategy
13.2.3. SWOT
13.3. Merck KGAA
13.3.1. Overview
13.3.2. Strategy
13.3.3. SWOT
13.4. Sartorius AG
13.4.1. Overview
13.4.2. Strategy
13.4.3. SWOT
13.5. Viral Inactivated Plasma Systems SA
13.5.1. Overview
13.5.2. Strategy
13.5.3. SWOT
13.6. Danaher Corporation
13.7. Parker Hannifin Corporation
13.8. Rad Source Technologies, Inc.
13.9. Texcell, Inc.
13.10. Wuxi Pharmatech Inc.
14. Appendix
14.1. Discussion Guide
14.2. 360iResearch Competitive Strategic Window
14.2.1. Leverage Zone
14.2.2. Vantage Zone
14.2.3. Speculative Zone
14.2.4. Bottleneck Zone
14.3. Top Reports
14.3.1. Global Crane Rental Market
14.3.2. Global Computer Vision Market
14.3.3. Global Payment Gateway Market
14.3.4. Global B2B Travel Market
14.3.5. Global Varicose Vein Treatment Devices Market
14.4. Author Details

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook